Jan 14, 2013, 08:00 AM by Michael Croft

Bio-IT World | GUEST COMMENTARY | Two years ago, venture capitalist Hermann Hauser boldly predicted the fall of Intel. The tech giant would be crushed, he said, by the mighty ARM (Advanced RISC Machines) Holdings. Such posturing is not uncommon in the world of technology, but the difference in this case was that Hauser was pointing to the business models of the two companies, not the technology per se.

Jan 14, 2013, 07:00 AM by Michael Croft

Edge | Edge has posted its annual question and there are some great responses: essays from Steve Pinker, Craig Venter, Brian Eno, Tim O’Reilly, Simon Baron-Cohen, Terry Sejnowski, Eric Topol, Nicholas Carr, Esther Dyson, Juan Enriquez, and a cast of 130 other scientific leaders.

Jan 11, 2013, 11:00 AM by Michael Croft

NGS Leaders | Justin Zook and Marc Salit from the National Institute of Standards and Technology report on the NIST workshop Genome in a Bottle, to develop reference materials, reference methods, and reference data to assess confidence in human whole genome variant calls.

Jan 11, 2013, 08:00 AM by Michael Croft

Jan 10, 2013, 14:00 PM by Michael Croft

Nature | Researchers at the University of Manchester have built a robotic ribosome, or at least a nanomachine  that can mimic some of a ribosome's activity.

Jan 10, 2013, 13:00 PM by Michael Croft

eWeek | A Gartner study suggests that the rising costs of big data storage is going to lead some businesses trade, barter, or sell their data for funds by 2016.

Jan 10, 2013, 09:00 AM by Michael Croft

InfoWorld | InfoWorld's Technology of the Year awards recognizes the best tech solutions from 2012. Among them, hardware, software, cloud solutions, and more.

Jan 9, 2013, 10:00 AM by Michael Croft

Bio-IT World | SINGAPORE—Bayer HealthCare has launched an Integrated Translational Oncology Network in Singapore to facilitate drug discovery and development specifically for cancers prevalent in Asian populations.  

Jan 8, 2013, 06:55 AM by Michael Croft

Bio-IT World | The two giants of next-generation sequencing technology, Illumina and Life Technologies, have announced rival initiatives with leading medical institutions in Boston to further the integration of their technology into the clinical genomics arena. Life is investing in Claritas Genomics with Boston Children's Hospital, while Illumina announced the founding members of the GeneInsight-Illumina Network.

Jan 7, 2013, 15:00 PM by Michael Croft

Wall Street Journal Blogs | Data scientists need to have a hybrid set of IT skills, says one big data professional. In a shift from big data (focus on the data) to data science (focus on the science), data-science-oriented disciplines like information-based medicine aim to leverage all sources of data to develop new scientific methods of inquiry.

Jan 7, 2013, 09:00 AM by Michael Croft

Pittsburgh Business Times | The University of Pittsburgh Schools of Health Services is launching a new Institute of Personalized Medicine to use genetics, genomics and related information from other disciplines to advance evidence-based medicine, practices and procedures that have been proven effective.

Jan 7, 2013, 09:00 AM by Michael Croft

Bio-IT World | The pharmaceutical industry could use a fortuneteller. According to a March 2010 issue of Nature Reviews Drug Discovery, drug companies spend on average $1.8 billion dollars to bring a new therapy to market, and that number is estimated to increase in the coming years. This staggering figure is due in part to the lack of predictive algorithms.

Jan 7, 2013, 08:00 AM by Michael Croft

Jan 4, 2013, 13:00 PM by Michael Croft

eWeek | 2013 will look better, but the tech market will fully rebound in 2014, a report from Forrester predicts. Cloud computing will continue to grow, along with mobility and smart computing.

Jan 4, 2013, 13:00 PM by Michael Croft

Jan 4, 2013, 08:00 AM by Michael Croft

Bloomberg | The Wellcome Trust has started an investment arm with 200 million pounds ($326 million) of initial capital for biotech. Syncona Partners will support new businesses in the medical-device, therapeutics, diagnostics and information-technology industries.

Jan 4, 2013, 08:00 AM by Michael Croft

News Brief | Biogen Idec has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of a treatment for hemophilia B.

Jan 4, 2013, 07:00 AM by Michael Croft

Bio-IT World | It all began five years ago when Anne Morriss, an economic development consultant, and her partner decided to use a sperm bank to conceive a child. They studiously reviewed the profiles of hundreds of potential donors, but genetics was an afterthought. “We chose a wonderful donor,” says Morriss, “but he was a carrier for a rare Mendelian disorder called MCADD.” Unbeknownst to Morris, she was a carrier too.   

Jan 3, 2013, 14:00 PM by Michael Croft

Discover Magazine | Researchers were able to turn off the agouti gene in mice--responsible for making most carrier mice overweight and prone to diabetes and cancer--with maternal diet.

Jan 3, 2013, 12:00 PM by Michael Croft

Forbes | NPS Pharmaceuticals is pricing Gattex, its drug for short bowel syndrome, at $295,000 per patient per year. How did they arrive at that number?